Zoonotic pathogens very likely caused the last pandemic. Can we get better at halting them before the next one?
NHS data shows mounting pressure from ‘quad-demic’ of viruses
Moderna, Pfizer, CureVac and Novavax register gains as health agency stresses risk to public ‘remains low’
Research adds to evidence that viral infections contribute to development of dementia
The lively, chattering mind can surprise us with its twists and turns
The risks of operating included blindness, deafness, infection and stroke. Who would emerge on the other side, I wondered
NHS data shows number of people in hospital with the illness has quadrupled over past month
The progress of new discoveries must be celebrated
Autolus hopes its less gruelling Car-T treatment for a type of leukaemia will allow it to compete with bigger rivals
Several factors could be contributing but experts are yet to reach a consensus on an explanation for the rapid decline
Boss David Epstein hopes to replicate his success at Seagen after $43bn sale last year
In this monthly series, running alongside our existing Tech Exchange dialogues, FT journalists talk to the scientists, developers and business leaders exploring ever more applications for artificial intelligence, in every aspect of our lives
Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’s
Fatty molecules also found in UPFs seen at high levels in colorectal tumours
This is a time for treating people as individuals rather than as members of a tribe
Jay Bhattacharya at the NIH would be the latest ally of Robert F Kennedy Jr to take a role overseeing US healthcare
Effort to understand cellular functions promises to unlock crucial information about personal health
Sharp rise in cases over 30 years compounded by millions of people lacking access to medication, Lancet study finds
People prone to breast cancer and diabetes among beneficiaries of early testing
Initiative is part of growing international efforts to give early warning of pandemic threats
Abbott Laboratories’ ‘virus hunters’ are tracking disease risks exacerbated by climate change
Also in today’s newsletter, can biodiversity credits avoid the blowback that’s hit the carbon credit market?
Since last October, the families of every fallen soldier have been offered postmortem sperm retrieval
Treating today’s mental and physical conditions may be a challenge, but their prevalence is actually a good sign
Analysis points to potential of drugs such as Ozempic beyond tackling obesity and diabetes
